|
Fusion gene ID: 19699 |
FusionGeneSummary for LIFR_C9 |
Fusion gene summary |
Fusion gene information | Fusion gene name: LIFR_C9 | Fusion gene ID: 19699 | Hgene | Tgene | Gene symbol | LIFR | C9 | Gene ID | 3977 | 1645 |
Gene name | LIF receptor alpha | aldo-keto reductase family 1 member C1 | |
Synonyms | CD118|LIF-R|SJS2|STWS|SWS | 2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB | |
Cytomap | 5p13.1 | 10p15.1 | |
Type of gene | protein-coding | protein-coding | |
Description | leukemia inhibitory factor receptorCD118 antigenLIF receptorleukemia inhibitory factor receptor alpha | aldo-keto reductase family 1 member C120 alpha-hydroxysteroid dehydrogenasealdo-keto reductase Cchlordecone reductase homolog HAKRCdihydrodiol dehydrogenase 1dihydrodiol dehydrogenase 1/2dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | P42702 | P02748 | |
Ensembl transtripts involved in fusion gene | ENST00000263409, ENST00000453190, ENST00000503088, | ENST00000263408, ENST00000509186, | |
Fusion gene scores | * DoF score | 5 X 5 X 5=125 | 5 X 4 X 3=60 |
# samples | 5 | 5 | |
** MAII score | log2(5/125*10)=-1.32192809488736 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/60*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: LIFR [Title/Abstract] AND C9 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | Tumor suppressor gene involved fusion gene, in-frame but not retained their domain. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | LIFR | GO:0008284 | positive regulation of cell proliferation | 7957045|8999038 |
Hgene | LIFR | GO:0019221 | cytokine-mediated signaling pathway | 7957045 |
Hgene | LIFR | GO:0034097 | response to cytokine | 8999038 |
Hgene | LIFR | GO:0048861 | leukemia inhibitory factor signaling pathway | 8999038|12643274 |
Hgene | LIFR | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway | 12643274 |
Tgene | C9 | GO:0007586 | digestion | 8486699 |
Tgene | C9 | GO:0008206 | bile acid metabolic process | 8486699 |
Tgene | C9 | GO:0030855 | epithelial cell differentiation | 21492153 |
Tgene | C9 | GO:0042448 | progesterone metabolic process | 21232532 |
Tgene | C9 | GO:0042574 | retinal metabolic process | 21851338 |
Tgene | C9 | GO:0051260 | protein homooligomerization | 8486699 |
Tgene | C9 | GO:0055114 | oxidation-reduction process | 8486699|19442656|21232532 |
Tgene | C9 | GO:0071395 | cellular response to jasmonic acid stimulus | 19487289 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | BRCA | TCGA-A7-A26G-01A | LIFR | chr5 | 38493708 | - | C9 | chr5 | 39316131 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000263409 | ENST00000263408 | LIFR | chr5 | 38493708 | - | C9 | chr5 | 39316131 | - |
5CDS-5UTR | ENST00000263409 | ENST00000509186 | LIFR | chr5 | 38493708 | - | C9 | chr5 | 39316131 | - |
Frame-shift | ENST00000453190 | ENST00000263408 | LIFR | chr5 | 38493708 | - | C9 | chr5 | 39316131 | - |
5CDS-5UTR | ENST00000453190 | ENST00000509186 | LIFR | chr5 | 38493708 | - | C9 | chr5 | 39316131 | - |
5UTR-3CDS | ENST00000503088 | ENST00000263408 | LIFR | chr5 | 38493708 | - | C9 | chr5 | 39316131 | - |
5UTR-5UTR | ENST00000503088 | ENST00000509186 | LIFR | chr5 | 38493708 | - | C9 | chr5 | 39316131 | - |
Top |
FusionProtFeatures for LIFR_C9 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
LIFR | C9 |
Signal-transducing molecule. May have a common pathwaywith IL6ST. The soluble form inhibits the biological activity ofLIF by blocking its binding to receptors on target cells. | Constituent of the membrane attack complex (MAC) thatplays a key role in the innate and adaptive immune response byforming pores in the plasma membrane of target cells(PubMed:9634479, PubMed:9212048, PubMed:26841934). C9 is the pore-forming subunit of the MAC (PubMed:4055801, PubMed:26841934).{ECO:0000269|PubMed:26841934, ECO:0000269|PubMed:4055801,ECO:0000269|PubMed:9212048, ECO:0000269|PubMed:9634479}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | LIFR | chr5:38493708 | chr5:39316131 | ENST00000263409 | - | 14 | 20 | 335_434 | 688 | 1098 | Domain | Fibronectin type-III 2 |
Hgene | LIFR | chr5:38493708 | chr5:39316131 | ENST00000263409 | - | 14 | 20 | 435_534 | 688 | 1098 | Domain | Fibronectin type-III 3 |
Hgene | LIFR | chr5:38493708 | chr5:39316131 | ENST00000263409 | - | 14 | 20 | 49_138 | 688 | 1098 | Domain | Fibronectin type-III 1 |
Hgene | LIFR | chr5:38493708 | chr5:39316131 | ENST00000263409 | - | 14 | 20 | 538_629 | 688 | 1098 | Domain | Fibronectin type-III 4 |
Hgene | LIFR | chr5:38493708 | chr5:39316131 | ENST00000453190 | - | 14 | 20 | 335_434 | 688 | 1098 | Domain | Fibronectin type-III 2 |
Hgene | LIFR | chr5:38493708 | chr5:39316131 | ENST00000453190 | - | 14 | 20 | 435_534 | 688 | 1098 | Domain | Fibronectin type-III 3 |
Hgene | LIFR | chr5:38493708 | chr5:39316131 | ENST00000453190 | - | 14 | 20 | 49_138 | 688 | 1098 | Domain | Fibronectin type-III 1 |
Hgene | LIFR | chr5:38493708 | chr5:39316131 | ENST00000453190 | - | 14 | 20 | 538_629 | 688 | 1098 | Domain | Fibronectin type-III 4 |
Hgene | LIFR | chr5:38493708 | chr5:39316131 | ENST00000263409 | - | 14 | 20 | 519_523 | 688 | 1098 | Motif | Note=WSXWS motif |
Hgene | LIFR | chr5:38493708 | chr5:39316131 | ENST00000453190 | - | 14 | 20 | 519_523 | 688 | 1098 | Motif | Note=WSXWS motif |
Tgene | >C9 | chr5:38493708 | chr5:39316131 | ENST00000263408 | - | 4 | 11 | 510_540 | 205 | 560 | Domain | Note=EGF-like |
Tgene | >C9 | chr5:38493708 | chr5:39316131 | ENST00000263408 | - | 4 | 11 | 314_330 | 205 | 560 | Transmembrane | Beta stranded |
Tgene | >C9 | chr5:38493708 | chr5:39316131 | ENST00000263408 | - | 4 | 11 | 335_354 | 205 | 560 | Transmembrane | Beta stranded |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >LIFR | chr5:38493708 | chr5:39316131 | ENST00000263409 | - | 14 | 20 | 627_719 | 688 | 1098 | Domain | Fibronectin type-III 5 |
Hgene | >LIFR | chr5:38493708 | chr5:39316131 | ENST00000263409 | - | 14 | 20 | 724_833 | 688 | 1098 | Domain | Fibronectin type-III 6 |
Hgene | >LIFR | chr5:38493708 | chr5:39316131 | ENST00000453190 | - | 14 | 20 | 627_719 | 688 | 1098 | Domain | Fibronectin type-III 5 |
Hgene | >LIFR | chr5:38493708 | chr5:39316131 | ENST00000453190 | - | 14 | 20 | 724_833 | 688 | 1098 | Domain | Fibronectin type-III 6 |
Hgene | >LIFR | chr5:38493708 | chr5:39316131 | ENST00000263409 | - | 14 | 20 | 869_877 | 688 | 1098 | Motif | Note=Box 1 motif |
Hgene | >LIFR | chr5:38493708 | chr5:39316131 | ENST00000453190 | - | 14 | 20 | 869_877 | 688 | 1098 | Motif | Note=Box 1 motif |
Hgene | >LIFR | chr5:38493708 | chr5:39316131 | ENST00000263409 | - | 14 | 20 | 45_833 | 688 | 1098 | Topological domain | Extracellular |
Hgene | >LIFR | chr5:38493708 | chr5:39316131 | ENST00000263409 | - | 14 | 20 | 859_1097 | 688 | 1098 | Topological domain | Cytoplasmic |
Hgene | >LIFR | chr5:38493708 | chr5:39316131 | ENST00000453190 | - | 14 | 20 | 45_833 | 688 | 1098 | Topological domain | Extracellular |
Hgene | >LIFR | chr5:38493708 | chr5:39316131 | ENST00000453190 | - | 14 | 20 | 859_1097 | 688 | 1098 | Topological domain | Cytoplasmic |
Hgene | >LIFR | chr5:38493708 | chr5:39316131 | ENST00000263409 | - | 14 | 20 | 834_858 | 688 | 1098 | Transmembrane | Helical |
Hgene | >LIFR | chr5:38493708 | chr5:39316131 | ENST00000453190 | - | 14 | 20 | 834_858 | 688 | 1098 | Transmembrane | Helical |
Tgene | C9 | chr5:38493708 | chr5:39316131 | ENST00000263408 | - | 4 | 11 | 138_509 | 205 | 560 | Domain | MACPF |
Tgene | C9 | chr5:38493708 | chr5:39316131 | ENST00000263408 | - | 4 | 11 | 42_95 | 205 | 560 | Domain | TSP type-1 |
Tgene | C9 | chr5:38493708 | chr5:39316131 | ENST00000263408 | - | 4 | 11 | 99_136 | 205 | 560 | Domain | LDL-receptor class A |
Top |
FusionGeneSequence for LIFR_C9 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_LIFR_ENST00000263409_chr5_38493708_-_C9_ENST00000263408_chr5_39316131_-_1043aa MMDIYVCLKRPSWMVDNKRMRTASNFQWLLSTFILLYLMNQVNSQKKGAPHDLKCVTNNLQVWNCSWKAPSGTGRGTDYEVCIENRSRSC YQLEKTSIKIPALSHGDYEITINSLHDFGSSTSKFTLNEQNVSLIPDTPEILNLSADFSTSTLYLKWNDRGSVFPHRSNVIWEIKVLRKE SMELVKLVTHNTTLNGKDTLHHWSWASDMPLECAIHFVEIRCYIDNLHFSGLEEWSDWSPVKNISWIPDSQTKVFPQDKVILVGSDITFC CVSQEKVLSALIGHTNCPLIHLDGENVAIKIRNISVSASSGTNVVFTTEDNIFGTVIFAGYPPDTPQQLNCETHDLKEIICSWNPGRVTA LVGPRATSYTLVESFSGKYVRLKRAEAPTNESYQLLFQMLPNQEIYNFTLNAHNPLGRSQSTILVNITEKVYPHTPTSFKVKDINSTAVK LSWHLPGNFAKINFLCEIEIKKSNSVQEQRNVTIKGVENSSYLVALDKLNPYTLYTFRIRCSTETFWKWSKWSNKKQHLTTEASPSKGPD TWREWSSDGKNLIIYWKPLPINEANGKILSYNVSCSSDEETQSLSEIPDPQHKAEIRLDKNDYIISVVAKNSVGSSPPSKIASMEIPNDD LKIEQVVGMGKGILLTWHYDPNMTCDYVIKWCNSSRSEPCLMDWRKVPSNSTETVIESDQRREKFQNRTLRRTNXSIXKYHPREDIKFXC SYISKIYTHXNKXSXTMLXGNSLLNFFTWQGXFSVFIFQKXNLPTIFVIFFKEGKNVSACERRNSSGKICNEKSRCCAHNNFCGXYKSFA NYLXKGRIFCLFGNLWNSLQXLWVSRRTLXTNICFGXSFHEAERCXTKRHKEMPWVSSGCISGFLXNLCWSXIXXRXLCKEGRGXSCKHH QXKPHRXCCFTHKRWNQKICIXTERKASPRNRDXCDXLCQLGLFHKXCSCSHXSKTVSYIXSGSSENEKCTPKETKLGKSHXRLYQXIXC |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_LIFR_ENST00000263409_chr5_38493708_-_C9_ENST00000263408_chr5_39316131_-_3130nt ATGATGGATATTTACGTATGTTTGAAACGACCATCCTGGATGGTGGACAATAAAAGAATGAGGACTGCTTCAAATTTCCAGTGGCTGTTA TCAACATTTATTCTTCTATATCTAATGAATCAAGTAAATAGCCAGAAAAAGGGGGCTCCTCATGATTTGAAGTGTGTAACTAACAATTTG CAAGTGTGGAACTGTTCTTGGAAAGCACCCTCTGGAACAGGCCGTGGTACTGATTATGAAGTTTGCATTGAAAACAGGTCCCGTTCTTGT TATCAGTTGGAGAAAACCAGTATTAAAATTCCAGCTCTTTCACATGGTGATTATGAAATAACAATAAATTCTCTACATGATTTTGGAAGT TCTACAAGTAAATTCACACTAAATGAACAAAACGTTTCCTTAATTCCAGATACTCCAGAGATCTTGAATTTGTCTGCTGATTTCTCAACC TCTACATTATACCTAAAGTGGAACGACAGGGGTTCAGTTTTTCCACACCGCTCAAATGTTATCTGGGAAATTAAAGTTCTACGTAAAGAG AGTATGGAGCTCGTAAAATTAGTGACCCACAACACAACTCTGAATGGCAAAGATACACTTCATCACTGGAGTTGGGCCTCAGATATGCCC TTGGAATGTGCCATTCATTTTGTGGAAATTAGATGCTACATTGACAATCTTCATTTTTCTGGTCTCGAAGAGTGGAGTGACTGGAGCCCT GTGAAGAACATTTCTTGGATACCTGATTCTCAGACTAAGGTTTTTCCTCAAGATAAAGTGATACTTGTAGGCTCAGACATAACATTTTGT TGTGTGAGTCAAGAAAAAGTGTTATCAGCACTGATTGGCCATACAAACTGCCCCTTGATCCATCTTGATGGGGAAAATGTTGCAATCAAG ATTCGTAATATTTCTGTTTCTGCAAGTAGTGGAACAAATGTAGTTTTTACAACCGAAGATAACATATTTGGAACCGTTATTTTTGCTGGA TATCCACCAGATACTCCTCAACAACTGAATTGTGAGACACATGATTTAAAAGAAATTATATGTAGTTGGAATCCAGGAAGGGTGACAGCG TTGGTGGGCCCACGTGCTACAAGCTACACTTTAGTTGAAAGTTTTTCAGGAAAATATGTTAGACTTAAAAGAGCTGAAGCACCTACAAAC GAAAGCTATCAATTATTATTTCAAATGCTTCCAAATCAAGAAATATATAATTTTACTTTGAATGCTCACAATCCGCTGGGTCGATCACAA TCAACAATTTTAGTTAATATAACTGAAAAAGTTTATCCCCATACTCCTACTTCATTCAAAGTGAAGGATATTAATTCAACAGCTGTTAAA CTTTCTTGGCATTTACCAGGCAACTTTGCAAAGATTAATTTTTTATGTGAAATTGAAATTAAGAAATCTAATTCAGTACAAGAGCAGCGG AATGTCACAATCAAAGGAGTAGAAAATTCAAGTTATCTTGTTGCTCTGGACAAGTTAAATCCATACACTCTATATACTTTTCGGATTCGT TGTTCTACTGAAACTTTCTGGAAATGGAGCAAATGGAGCAATAAAAAACAACATTTAACAACAGAAGCCAGTCCTTCAAAGGGGCCTGAT ACTTGGAGAGAGTGGAGTTCTGATGGAAAAAATTTAATAATCTATTGGAAGCCTTTACCCATTAATGAAGCTAATGGAAAAATACTTTCC TACAATGTATCGTGTTCATCAGATGAGGAAACACAGTCCCTTTCTGAAATCCCTGATCCTCAGCACAAAGCAGAGATACGACTTGATAAG AATGACTACATCATCAGCGTAGTGGCTAAAAATTCTGTGGGCTCATCACCACCTTCCAAAATAGCGAGTATGGAAATTCCAAATGATGAT CTCAAAATAGAACAAGTTGTTGGGATGGGAAAGGGGATTCTCCTCACCTGGCATTACGACCCCAACATGACTTGCGACTACGTCATTAAG TGGTGTAACTCGTCTCGGTCGGAACCATGCCTTATGGACTGGAGAAAAGTTCCCTCAAACAGCACTGAAACTGTAATAGAATCTGACCAA AGGCGAGAAAAATTTCAGAACCGAACATTACGAAGAACAAATTGAAGCATTTAAAAGTATCATCCAAGAGAAGACATCAAATTTTAATGC AGCTATATCTCTAAAATTTACACCCACTGAAACAAATAAAGCTGAACAATGTTGTGAGGAAACAGCCTCCTCAATTTCTTTACATGGCAA GGGTAGTTTTCGGTTTTCATATTCCAAAAATGAAACTTACCAACTATTTTTGTCATATTCTTCAAAGAAGGAAAAAATGTTTCTGCATGT GAAAGGAGAAATTCATCTGGGAAGATTTGTAATGAGAAATCGCGATGTTGTGCTCACAACAACTTTTGTGGATGATATAAAAGCTTTGCC AACTACCTATGAAAAGGGAGAATATTTTGCCTTTTTGGAAACCTATGGAACTCACTACAGTAGCTCTGGGTCTCTAGGAGGACTCTATGA ACTAATATATGTTTTGGATAAAGCTTCCATGAAGCGGAAAGGTGTTGAACTAAAAGACATAAAGAGATGCCTTGGGTATCATCTGGATGT ATCTCTGGCTTTCTCTGAAATCTCTGTTGGAGCTGAATTTAATAAAGATGATTGTGTAAAGAGGGGAGAGGGTAGAGCTGTAAACATCAC CAGTGAAAACCTCATAGATGATGTTGTTTCACTCATAAGAGGTGGAACCAGAAAATATGCATTTGAACTGAAAGAAAAGCTTCTCCGAGG AACCGTGATTGATGTGACTGACTTTGTCAACTGGGCCTCTTCCATAAATGATGCTCCTGTTCTCATTAGTCAAAAACTGTCTCCTATATA TAATCTGGTTCCAGTGAAAATGAAAAATGCACACCTAAAGAAACAAAACTTGGAAAGAGCCATTGAAGACTATATCAATGAATTTAGTGT AAGAAAATGCCACACATGCCAAAATGGAGGTACAGTGATTCTAATGGATGGAAAGTGTTTGTGTGCCTGCCCATTCAAATTTGAGGGAAT |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_LIFR_ENST00000263409_chr5_38493708_-_C9_ENST00000263408_chr5_39316131_-_4230nt AATCCTAACCCTCTCTCCCAGAACGTGTCTCTGCTGCAAGGCACCGGGCCCTTTCGCTCTGCAGAACTGCACTTGCAAGACCATTATCAA CTCCTAATCCCAGCTCAGAAAGGGAGCCTCTGCGACTCATTCATCGCCCTCCAGGACTGACTGCATTGCACAGATGATGGATATTTACGT ATGTTTGAAACGACCATCCTGGATGGTGGACAATAAAAGAATGAGGACTGCTTCAAATTTCCAGTGGCTGTTATCAACATTTATTCTTCT ATATCTAATGAATCAAGTAAATAGCCAGAAAAAGGGGGCTCCTCATGATTTGAAGTGTGTAACTAACAATTTGCAAGTGTGGAACTGTTC TTGGAAAGCACCCTCTGGAACAGGCCGTGGTACTGATTATGAAGTTTGCATTGAAAACAGGTCCCGTTCTTGTTATCAGTTGGAGAAAAC CAGTATTAAAATTCCAGCTCTTTCACATGGTGATTATGAAATAACAATAAATTCTCTACATGATTTTGGAAGTTCTACAAGTAAATTCAC ACTAAATGAACAAAACGTTTCCTTAATTCCAGATACTCCAGAGATCTTGAATTTGTCTGCTGATTTCTCAACCTCTACATTATACCTAAA GTGGAACGACAGGGGTTCAGTTTTTCCACACCGCTCAAATGTTATCTGGGAAATTAAAGTTCTACGTAAAGAGAGTATGGAGCTCGTAAA ATTAGTGACCCACAACACAACTCTGAATGGCAAAGATACACTTCATCACTGGAGTTGGGCCTCAGATATGCCCTTGGAATGTGCCATTCA TTTTGTGGAAATTAGATGCTACATTGACAATCTTCATTTTTCTGGTCTCGAAGAGTGGAGTGACTGGAGCCCTGTGAAGAACATTTCTTG GATACCTGATTCTCAGACTAAGGTTTTTCCTCAAGATAAAGTGATACTTGTAGGCTCAGACATAACATTTTGTTGTGTGAGTCAAGAAAA AGTGTTATCAGCACTGATTGGCCATACAAACTGCCCCTTGATCCATCTTGATGGGGAAAATGTTGCAATCAAGATTCGTAATATTTCTGT TTCTGCAAGTAGTGGAACAAATGTAGTTTTTACAACCGAAGATAACATATTTGGAACCGTTATTTTTGCTGGATATCCACCAGATACTCC TCAACAACTGAATTGTGAGACACATGATTTAAAAGAAATTATATGTAGTTGGAATCCAGGAAGGGTGACAGCGTTGGTGGGCCCACGTGC TACAAGCTACACTTTAGTTGAAAGTTTTTCAGGAAAATATGTTAGACTTAAAAGAGCTGAAGCACCTACAAACGAAAGCTATCAATTATT ATTTCAAATGCTTCCAAATCAAGAAATATATAATTTTACTTTGAATGCTCACAATCCGCTGGGTCGATCACAATCAACAATTTTAGTTAA TATAACTGAAAAAGTTTATCCCCATACTCCTACTTCATTCAAAGTGAAGGATATTAATTCAACAGCTGTTAAACTTTCTTGGCATTTACC AGGCAACTTTGCAAAGATTAATTTTTTATGTGAAATTGAAATTAAGAAATCTAATTCAGTACAAGAGCAGCGGAATGTCACAATCAAAGG AGTAGAAAATTCAAGTTATCTTGTTGCTCTGGACAAGTTAAATCCATACACTCTATATACTTTTCGGATTCGTTGTTCTACTGAAACTTT CTGGAAATGGAGCAAATGGAGCAATAAAAAACAACATTTAACAACAGAAGCCAGTCCTTCAAAGGGGCCTGATACTTGGAGAGAGTGGAG TTCTGATGGAAAAAATTTAATAATCTATTGGAAGCCTTTACCCATTAATGAAGCTAATGGAAAAATACTTTCCTACAATGTATCGTGTTC ATCAGATGAGGAAACACAGTCCCTTTCTGAAATCCCTGATCCTCAGCACAAAGCAGAGATACGACTTGATAAGAATGACTACATCATCAG CGTAGTGGCTAAAAATTCTGTGGGCTCATCACCACCTTCCAAAATAGCGAGTATGGAAATTCCAAATGATGATCTCAAAATAGAACAAGT TGTTGGGATGGGAAAGGGGATTCTCCTCACCTGGCATTACGACCCCAACATGACTTGCGACTACGTCATTAAGTGGTGTAACTCGTCTCG GTCGGAACCATGCCTTATGGACTGGAGAAAAGTTCCCTCAAACAGCACTGAAACTGTAATAGAATCTGACCAAAGGCGAGAAAAATTTCA GAACCGAACATTACGAAGAACAAATTGAAGCATTTAAAAGTATCATCCAAGAGAAGACATCAAATTTTAATGCAGCTATATCTCTAAAAT TTACACCCACTGAAACAAATAAAGCTGAACAATGTTGTGAGGAAACAGCCTCCTCAATTTCTTTACATGGCAAGGGTAGTTTTCGGTTTT CATATTCCAAAAATGAAACTTACCAACTATTTTTGTCATATTCTTCAAAGAAGGAAAAAATGTTTCTGCATGTGAAAGGAGAAATTCATC TGGGAAGATTTGTAATGAGAAATCGCGATGTTGTGCTCACAACAACTTTTGTGGATGATATAAAAGCTTTGCCAACTACCTATGAAAAGG GAGAATATTTTGCCTTTTTGGAAACCTATGGAACTCACTACAGTAGCTCTGGGTCTCTAGGAGGACTCTATGAACTAATATATGTTTTGG ATAAAGCTTCCATGAAGCGGAAAGGTGTTGAACTAAAAGACATAAAGAGATGCCTTGGGTATCATCTGGATGTATCTCTGGCTTTCTCTG AAATCTCTGTTGGAGCTGAATTTAATAAAGATGATTGTGTAAAGAGGGGAGAGGGTAGAGCTGTAAACATCACCAGTGAAAACCTCATAG ATGATGTTGTTTCACTCATAAGAGGTGGAACCAGAAAATATGCATTTGAACTGAAAGAAAAGCTTCTCCGAGGAACCGTGATTGATGTGA CTGACTTTGTCAACTGGGCCTCTTCCATAAATGATGCTCCTGTTCTCATTAGTCAAAAACTGTCTCCTATATATAATCTGGTTCCAGTGA AAATGAAAAATGCACACCTAAAGAAACAAAACTTGGAAAGAGCCATTGAAGACTATATCAATGAATTTAGTGTAAGAAAATGCCACACAT GCCAAAATGGAGGTACAGTGATTCTAATGGATGGAAAGTGTTTGTGTGCCTGCCCATTCAAATTTGAGGGAATTGCCTGTGAAATCAGTA AACAAAAAATTTCTGAAGGATTGCCAGCCCTAGAGTTCCCCAATGAAAAATAGAGCTGTTGGCTTCTCTGAGCTCCAGTGGAAGAAGAAA ACACTAGTACCTTCAGATCCTACCCCTGAAGATAATCTTAGCTGCCAAGTAAATAGCAACATGCTTCATGAAAATCCTACCAACCTCTGA AGTCTCTTCTCTCTTAGGTCTATAATTTTTTTTTAAATTTTTCTTCCTTAAACTCCTGTGATGTTTCCATTTTTTGTTCCCTAATGAGAA GTCAACAGTGAAATACGCCAGAACTGCTTTATCCCACGGAAAATGCCAATCTCTTCTAAAAAAAAACAAAATTAAATTAAAAACAGAATG TTGGTTTAAAAAACTTCAAAGTAATTTTCAAACGGCTTTGTATGGTTAACATATTCTGCCAGGTCCATGACCACACGTCTGTACCATGCA ATTTAACTCTTATTTACATTGTTATGTTTAGTTTGGTTATTTGCTTAGGTGTGCATACATTCATTCAGCAAATGCTGAGCACCAGCCACG TGCACAGCAGTTGCTTTTACTAGTCTTAGCTCTACGATTTAAATCCATGTGTCCAAGGGGGAAAACATATTATATTTGTAACCAAAAACT ACTAGTTTACCAGAGGACTGAAGGGAGATAAAGAGGAGTTGGTTAATGGGTACAAAAATCCAGTTAGATGAAAGGAATAATATAGATAGT GTTCAGTAGCAGAATAGAATGAACATAAACTATTAGTTTAAATTATGTGAAATTCCTTCTATTTGATCATATTTTACAAGAAAAAACATC AATTTTATATAGTCCAACTTAATACCTAGCCTTATGAGTTGTATAAGGTAAGGTTACCTACCTGAGAAGCTGATTAACATTGGTTGTACA ATCTTATTCATTAGAGAACATGGTGCTTAGGGTCTGAGACCTTTTGAAAGGTCTGAGAACTCTTTAAAAAAAGGAAAGAAAGAAAGAAAA |
Top |
FusionGenePPI for LIFR_C9 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
LIFR | CNTFR, LIF, OSM, IL6ST, PTPN6, FBXO6, PRPF4, BAG3, GOLT1B, SCGB1D1, DEFA1, FAM19A4, SLAMF1, TRIM25 | C9 | CLU, CD59, FN1, LAMTOR5, APOE, CST6 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for LIFR_C9 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for LIFR_C9 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | LIFR | C0796176 | STUVE-WIEDEMANN SYNDROME | 2 | CTD_human;ORPHANET;UNIPROT |
Hgene | LIFR | C0032460 | Polycystic Ovary Syndrome | 1 | CTD_human |
Hgene | LIFR | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Hgene | LIFR | C0036341 | Schizophrenia | 1 | PSYGENET |
Hgene | LIFR | C0349398 | Paranoid delusion | 1 | PSYGENET |
Tgene | C9 | C0021051 | Immunologic Deficiency Syndromes | 2 | CTD_human |
Tgene | C9 | C0011633 | Dermatomyositis | 1 | CTD_human |
Tgene | C9 | C0015456 | Facial Dermatoses | 1 | CTD_human |
Tgene | C9 | C0025294 | Meningococcal meningitis | 1 | CTD_human |
Tgene | C9 | C0027412 | Opioid-Related Disorders | 1 | CTD_human |
Tgene | C9 | C0041834 | Erythema | 1 | CTD_human |
Tgene | C9 | C0242383 | Age related macular degeneration | 1 | CTD_human |
Tgene | C9 | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Tgene | C9 | C2239176 | Liver carcinoma | 1 | CTD_human |
Tgene | C9 | C3151189 | C9 Deficiency | 1 | UNIPROT |
Tgene | C9 | C3810042 | MACULAR DEGENERATION, AGE-RELATED, 15 | 1 | UNIPROT |